Evidence of the Effects of Healthcare IT on Healthcare Outcomes

A study by the analytics division of HIMSS UK has, for the first time, highlighted a correlation between the maturity of IT within NHS hospitals and improvements to patient outcomes. The research, which combines data from 91 NHS hospitals in England together with HIMSS Europe's proprietary EMRAM capability data (Electronic Medical Record Adoption Model) demonstrates that those hospitals that have a score of EMRAM Stage 4 and above, have a lower Summary Hospital-Level Mortality Indicator (SHMI).

John Rayner, Director of Professional Development, HIMSS UK said the findings are a key justification of the investment in healthcare IT going forward: "This report asks us to accept as a general principle that hospitals that are more digitally mature can provide greater levels of patient safety and are more productive than hospitals that have not made investments in technology."

"The indicators that have been used as evidence are the foundations of a more compelling case on which we will build on but the report provides some real and long-awaited assurances that IT investment has absolute links to improving patient care and quality."

In addition to a decline in mortality rates, the study titled 'Evidence of the Effects of Healthcare IT on Healthcare Outcomes,' also found evidence of a positive correlation between EMR capabilities and imaging workflow performance, whereby digitised imaging departments were more efficient and effective at staying on top of workflow management.

In terms of patient feedback and only by a slight margin, hospitals tending towards a higher EMRAM score performed consistently better than their counterparts with lower EMRAM scores for treatment-related patient satisfaction questions.

Stephen Lieber, President and CEO of HIMSS added: "The correlation between these findings will come as no surprise to many of those working in healthcare IT. But for clinicians and patients alike they have the potential to encourage a real step-change in the attitudes towards the benefits of technology, meanwhile assisting professionals in building robust business cases.

"Interestingly, the study also highlights that only when a hospital has the fundamental building blocks in place such as an electronic patient record system and electronic clinical documentation and has reached HIMSS Stage 4, will it start to see these types of clinical benefits, demonstrating that in order to reap the rewards, IT must be a long-term and progressive investment."

Download: Evidence of the Effects of Healthcare IT on Healthcare Outcomes (.pdf, 507 KB).

Download from eHealthNews.eu: Evidence of the Effects of Healthcare IT on Healthcare Outcomes (.pdf, 507 KB).

About HIMSS Analytics
HIMSS Analytics collects, analyses and distributes essential health IT data related to products, costs, metrics, trends and purchase decisions. It delivers quality data and analytical expertise to healthcare delivery organisations, IT companies, governmental entities, financial, pharmaceutical and consulting companies.

HIMSS Analytics is a part of HIMSS, a cause-based global enterprise that produces health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share the cause of transforming health and healthcare through the best use of IT. HIMSS, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

About HIMSS
HIMSS WorldWide is a cause-based, not-for-profit global enterprise that produces health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS WorldWide encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share this cause. HIMSS WorldWide, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

HIMSS WorldWide has commissioned this report from Bilue, a London-based research & consulting start-up specializing in data-driven marketing and strategy solutions for the healthcare and biosciences markets.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...